Liu W H, Kaur M, Makrigiorgos G M
Department of Radiation Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Hum Mutat. 2003 May;21(5):535-41. doi: 10.1002/humu.10184.
Ethidium gel-based PCR-RFLP is widely used, and is perhaps the simplest method for detection of known mutations in cancer-related genes and for genotyping a wide range of other human diseases. However, its application is limited by the fact that it can only detect mutant alleles that are present in more than 5-10% of wild-type alleles. Here we present a method that allows a 1-2 order enhancement in the sensitivity of the widely used PCR-RFLP without substantially increasing the effort and cost associated with it. This method is a modification to our previously reported amplification via primer ligation at the mutation (APRIL-ATM) method, which utilizes ligation of a primer at a restriction site formed by a mutation, followed by a ligation-mediated PCR amplification which amplifies only the mutation-containing DNA molecules. By combining this method with the artificial introduction of restriction sites during PCR, we demonstrate that assays can be designed and validated for detecting hot-spot mutations in codons 273, 158, and 248 of the TP53 gene (p53) and potentially for most mutations of interest. This approach is validated by using samples where the mutation was artificially introduced at these p53 positions. The increased sensitivity offered by the method further allows us to rapidly screen for low frequency polymorphisms in pooled DNA samples. The frequency of an MSH2 missense polymorphism (965G>A) was quantified in pooled genomic DNA samples from 205 and 221 U.S. and Polish colorectal cancer patients, respectively, and an equal number of ethnicity-matched controls. The data revealed a 3-5% prevalence of this polymorphism in the patient and the control populations. Individual sequencing of all 852 patient samples demonstrated an excellent agreement among the two independent approaches. The present enhanced PCR-RFLP reduces the effort involved in high throughput polymorphism studies and promises to find applications in genotyping and association studies involving low frequency polymorphisms and mutations.
基于溴化乙锭凝胶的聚合酶链反应-限制性片段长度多态性分析(PCR-RFLP)被广泛应用,它可能是检测癌症相关基因中已知突变以及对多种其他人类疾病进行基因分型的最简单方法。然而,其应用受到限制,因为它只能检测到野生型等位基因中占比超过5% - 10%的突变等位基因。在此,我们提出一种方法,可使广泛使用的PCR-RFLP灵敏度提高1 - 2个数量级,同时不会大幅增加与之相关的工作量和成本。该方法是对我们之前报道的通过突变位点引物连接进行扩增(APRIL-ATM)方法的改进,该方法利用引物在由突变形成的限制性位点处进行连接,随后进行连接介导的PCR扩增,仅扩增含突变的DNA分子。通过将此方法与PCR过程中人工引入限制性位点相结合,我们证明可以设计并验证用于检测TP53基因(p53)第273、158和248密码子热点突变的检测方法,并且可能适用于大多数感兴趣的突变。通过使用在这些p53位置人工引入突变的样本对该方法进行了验证。该方法提供的更高灵敏度进一步使我们能够快速筛选混合DNA样本中的低频多态性。分别对来自205名美国和221名波兰结直肠癌患者以及相同数量种族匹配对照的混合基因组DNA样本中MSH2错义多态性(965G>A)的频率进行了定量分析。数据显示该多态性在患者和对照人群中的患病率为3% - 5%。对所有852份患者样本进行的个体测序表明,这两种独立方法之间具有极好的一致性。目前改进的PCR-RFLP减少了高通量多态性研究所需的工作量,并有望在涉及低频多态性和突变的基因分型及关联研究中得到应用。